Veterinary Medicine Information website

NOBILIS RT + IBmulti + G + ND

Authorised
  • Infectious bursal disease virus, strain D78, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
Download as PDF

Product identification

Medicine name:
NOBILIS RT + IBmulti + G + ND
Active substance:
  • Infectious bursal disease virus, strain D78, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
Target species:
  • Chicken (for reproduction)
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain D78, Inactivated
    14.00
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Newcastle disease virus, strain Clone 30, Inactivated
    50.00
    50% Protective Dose
    /
    0.50
    millilitre(s)
  • Infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    5.50
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Turkey rhinotracheitis virus, strain BUT1#8544, Inactivated
    9.50
    log2 enzyme-linked immunosorbent assay unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Available in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 140152
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 12/12/2024
Download